| [1] |
ZAN Ke, ZHAO Lei, JIANG Dacheng, WANG Ying, JIN Hongyu, MA Yu, MA Shuangcheng.
Determination of 135 pesticide residues in Farfarae Flos by UPLC-MS/MS and risk assessment
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 885-890.
|
| [2] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
| [3] |
WANG Ran, LI Yifan, LIU Xiaoyan, FENG Xin.
One case of pharmaceutical care of drug exposure during pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 933-934.
|
| [4] |
WANG Ran, FENG Xin, DU Boran.
Advances in risk assessment and pharmaceutical care of pregnancy medication exposure during perinatal period
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 836-840.
|
| [5] |
NIE Lixing, WANG Xinping, LI Jing, DAI Zhong, KANG Shuai, MA Shuangcheng.
Content analysis and risk assessment of aristolochic acids in Chinese medicinal materials (decoction pieces)
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 553-559.
|
| [6] |
YAO Keyu, ZHANG Shuqi, JIN Rui, LIU Lihong, ZHU Yan.
Comparative study on data set of drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 568-573.
|
| [7] |
NIE Lixing, CHEN Jia, ZHANG Ye, ZHAO Hui, DAI Zhong, MA Shuangcheng.
Comprehensive tests and risk assessment of exogenous harmful residues in Isatidis Radix
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 379-382.
|
| [8] |
LI Hailiang, LIU Yuanxi, WANG Zhao, ZAN Ke, WANG Ying, JIN Hongyu, MA Shuangcheng.
Transfer behavior and risk assessment of pesticide residue during the processing of Chrysanthemum morifolium
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1228-1233.
|
| [9] |
ZHONG Yingying, WANG Zhao, ZUO Tiantian, LI Yaolei, LI Hailiang, MA Shuangcheng.
Research progress on detection and risk assessment of exogenous heavy metals and related elements in Codonopsis Radix
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1309-1315.
|
| [10] |
ZUO Tiantian, WANG Zhao, GUO Yuansheng, WEI Feng, JIN Hongyu, MA Shuangcheng.
Non-carcinogenic and carcinogenic risk assessment of toxic elements in Panax quinquefolium L. based on multi-element semi-quantitative screening
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1108-1112.
|
| [11] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
| [12] |
WEN Hairuo, WANG Yanan, JIANG Hua, WANG Xue, WANG Qi, MA Shuangcheng.
In vivo genotoxic risk assessment of emodin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 635-640.
|
| [13] |
ZHANG Xiaomeng, LYU Jintao, ZHANG Bing, LIN Zhijian, LIU Rongxue.
Risk assessment and pre-warning of injection within Bufonis Venenum in the treatment of liver cancer
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 469-474.
|
| [14] |
LI Yaolei, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, ZAN Ke, JIN Hongyu, MA Shuangcheng.
Research on the application of clinical drug-oriented risk assessment method for harmful components of traditional Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 475-480.
|
| [15] |
ZAN Ke, ZHOU Ying, LI Yaolei, WANG Ying, JIN Hongyu, ZUO Tiantian, MA Shuangcheng.
Content determination and health risk assessment of pyrrolizidine alkaloid N-oxides in Vignae Semen
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1186-1190.
|
